Back
Nutex Health Quote, Financials, Valuation and Earnings
Sponsored
NUTX
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
58
NUTX
Nutex Health
Last Price:
32.98
Seasonality Move:
-16.36%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeNutex Health Price Quote
$32.98
+0.36 (+1.1%)
(Updated: November 14, 2024 at 1:05 PM ET)
Nutex Health Key Stats
Buy
58
Nutex Health (NUTX)
is a Buy
Day range:
$32.20 - $38.00
52-week range:
$4.16 - $39.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.48
P/B ratio:
3.03%
Volume:
100K
Avg. volume:
62.5K
1-year change:
-13.39%
Market cap:
$190.3M
Revenue:
$247.6M
EPS:
$-10.57
How Much Does Nutex Health Make?
-
How Much Are Nutex Health's Sales Annually?
NUTX Revenues are $247.6M -
How Much Profit Does Nutex Health's Make A Year?
NUTX net income is -$45.8M
Is Nutex Health Growing As A Company?
-
What Is Nutex Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.29% -
What Is Nutex Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Nutex Health Stock Price Performance
-
Did Nutex Health Stock Go Up Last Month?
Nutex Health share price went up by 64.83% last month -
Did NUTX's Share Price Rise Over The Last Year?
NUTX share price fell by -13.39% over the past 1 year
What Is Nutex Health 52-Week High & Low?
-
What Is Nutex Health’s 52-Week High Share Price?
Nutex Health has traded as high as $39.48 over the past 52 weeks -
What Is Nutex Health’s 52-Week Low Share Price?
Nutex Health has traded as low as $4.16 over the past 52 weeks
Nutex Health Price To Free Cash Flow
-
Is Nutex Health Stock Overvalued?
Nutex Health is trading at a price to free cash flow ratio of 10.09 -
Is Nutex Health Stock Undervalued?
Nutex Health EV to Free Cash Flow ratio is 15.83 -
What Is Nutex Health’s Price Earnings Growth Ratio?
NUTX PEG ratio is 0.00 -
Is Nutex Health Trading At A Premium To Earnings?
Nutex Health EV to EBIT ratio is 0.00
Is It Risky To Buy Nutex Health?
-
How Much Debt Does Nutex Health Have?
Total long term debt quarterly is $39.5M -
How Much Cash Does Nutex Health Have?
Cash and short term investments quarterly total is $40.8M -
What Is Nutex Health’s Book Value Per Share?
Book value per share is 12.58
Is Nutex Health Cash Flow Positive?
-
What Is NUTX Cash Flow From Operations?
Cash flow from operations (TTM) is $16.5M -
What Is Nutex Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$3.7M -
What Is Nutex Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.8M
Nutex Health Return On Invested Capital
-
Is Management Doing A Good Job?
NUTX return on invested capital is -28.72% -
What Is Nutex Health Return On Assets?
ROA measures how assets are converting to revenues and is -8.85% -
What Is NUTX Return On Equity?
ROE is a measure of profitability and is -41.7%
Nutex Health Earnings Date & Stock Price
-
What Is Nutex Health's Stock Price Today?
A single share of NUTX can be purchased today for 32.62 -
What Is Nutex Health’s Stock Symbol?
Nutex Health trades on the nasdaq under the ticker symbol: NUTX -
When Is Nutex Health’s Next Earnings Date?
The next quarterly earnings date for Nutex Health is scheduled on March 14, 2025 -
When Is NUTX's next ex-dividend date?
Nutex Health's next ex-dividend date is November 14, 2024 -
How To Buy Nutex Health Stock?
You can buy Nutex Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Nutex Health Competitors
-
Who Are Nutex Health's Competitors?
Below is a list of companies who compete with Nutex Health or are related in some way:
Nutex Health Dividend Yield
-
What Is NUTX Dividend Yield?
Nutex Health’s dividend yield currently is 0% -
What Is Nutex Health’s Payout Ratio?
Nutex Health’s payout ratio is -11.59% -
When Did Nutex Health Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Nutex Health’s Dividend Per Share?
Nutex Health pays a dividend of $0.00 per share
Nutex Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -213.9% |
Revenue: | 29.12% | 7.61% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 52.50 |
Upside from Last Price: | 60.94% |